Ledger.Open graph →
SEC Form D · Amendment · filed October 4, 2017

Hoverink Biotechnologies, Inc

Offering
$100.0M
Sold
—
Exemption
Rule 506(c)
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (9)

Cyrus Sajna · Los Angeles, CAExec · DirectorDavidra N. Sajna · Los Angeles, CAExec · DirectorDebbie Mae Carter · Los Angeles, CAExec · DirectorAEI Net Lease Portfolio XI Depositor, LLC · St. Paul, MNExec · DirectorSteven Jacolow · Tampa, FLExec · DirectorWilliam A. Timmerman Iii · Newtown Square, PAExec · DirectorHans P. Morefield · East Rochester, NYExec · DirectorJohn P. Holton · East Rochester, NYExec · DirectorTimothy G. Tyler · Needham, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗